Enobosarm, better known as as Ostarine or MK 2866, is a Selective Androgen Receptor Modulator (SARM) developed by GTx (GTx-024) to combat muscle wasting and osteoporosis. Many speculate
Ostarine may find uses in hormone replacement treatment plans, as well as in the treatment of
sarcopenia, cachexia and muscle atrophy. This is a highly valuable benefit to those suffering from
muscle wasting diseases, more so because SARM's have been shown to not have an impact on
non-skeletal muscle.

Ostarine Traits:
As a SARM, Ostarine binds directly to the androgen receptors. While anabolic steroids also bind to androgen receptors, SARM's cannot convert to DHT or estrogen. Officially belonging to a group of drugs, Ligand, MK 2866's only purpose is direct anabolic activity. This SARM can be used for muscle growth or muscle preservation (diet dependent).

Test 600xOs:
Ostarine, like anabolic steroids, will increase protein synthesis as well as nitrogen retention. However,
unlike anabolic steroids, it will do so without any DHTor estrogen conversion.
While no direct estrogen conversion is present in terms of aromatase activity, mild increases in estrogen levels have been shown. This is perhaps why Ostarine has been shown to be good for joint health and
healing. Estrogen often gets a bad wrap, but some is needed for good health and physical performance. It is,however, the direct binding to the receptor that is most important as it not only promotes anabolism, it
alters the gene sequence directly at the receptor site; in fact, it is highly tissue specific, muscle and bone.

Usage